Erste Asset Management’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $331K | Hold |
51,200
| – | – | ﹤0.01% | 700 |
|
|
2025
Q1 | $413K | Hold |
51,200
| – | – | 0.01% | 440 |
|
|
2024
Q4 | $659K | Hold |
51,200
| – | – | 0.01% | 417 |
|
|
2024
Q3 | $725K | Hold |
51,200
| – | – | 0.01% | 405 |
|
|
2024
Q2 | $708K | Hold |
51,200
| – | – | 0.01% | 397 |
|
|
2024
Q1 | $808K | Hold |
51,200
| – | – | 0.01% | 388 |
|
|
2023
Q4 | $767K | Hold |
51,200
| – | – | 0.01% | 395 |
|
|
2023
Q3 | $635K | Hold |
51,200
| – | – | 0.01% | 384 |
|
|
2023
Q2 | $628K | Hold |
51,200
| – | – | 0.01% | 398 |
|
|
2023
Q1 | $653K | Buy |
+51,200
| New | +$653K | 0.01% | 403 |
|